242 related articles for article (PubMed ID: 36809085)
21. Treatment of hepatitis E virus.
Dalton HR; Kamar N
Curr Opin Infect Dis; 2016 Dec; 29(6):639-644. PubMed ID: 27607911
[TBL] [Abstract][Full Text] [Related]
22. Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver.
Sayed IM; Verhoye L; Cocquerel L; Abravanel F; Foquet L; Montpellier C; Debing Y; Farhoudi A; Wychowski C; Dubuisson J; Leroux-Roels G; Neyts J; Izopet J; Michiels T; Meuleman P
Gut; 2017 May; 66(5):920-929. PubMed ID: 27006186
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis E Virus Mutations: Functional and Clinical Relevance.
van Tong H; Hoan NX; Wang B; Wedemeyer H; Bock CT; Velavan TP
EBioMedicine; 2016 Sep; 11():31-42. PubMed ID: 27528267
[TBL] [Abstract][Full Text] [Related]
24. Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation.
Allweiss L; Gass S; Giersch K; Groth A; Kah J; Volz T; Rapp G; Schöbel A; Lohse AW; Polywka S; Pischke S; Herker E; Dandri M; Lütgehetmann M
J Hepatol; 2016 May; 64(5):1033-1040. PubMed ID: 26805671
[TBL] [Abstract][Full Text] [Related]
25. Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro.
Nishiyama T; Kobayashi T; Jirintai S; Nagashima S; Primadharsini PP; Nishizawa T; Okamoto H
Antiviral Res; 2019 Oct; 170():104570. PubMed ID: 31362004
[TBL] [Abstract][Full Text] [Related]
26. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
[TBL] [Abstract][Full Text] [Related]
27. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
[TBL] [Abstract][Full Text] [Related]
28. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of antiviral efficacy of Chinese traditional medicine Babao Dan in rabbits infected with hepatitis E virus.
Gong W; Liu L; Li M; Wang L; Zhang M; Luo Z; Sridhar S; Woo PCY; Wang L
J Gen Virol; 2018 Aug; 99(8):1036-1043. PubMed ID: 29923821
[TBL] [Abstract][Full Text] [Related]
30. Substitution of amino acid residue V1213 in the helicase domain of the genotype 3 hepatitis E virus reduces virus replication.
Cao D; Ni YY; Meng XJ
Virol J; 2018 Feb; 15(1):32. PubMed ID: 29422085
[TBL] [Abstract][Full Text] [Related]
31. Detection of Hepatitis E Virus in Rabbits and Rabbit Meat from Slaughterhouses in Hebei Province of China.
Zhang H; Li X; Wang C; Shi T; Geng Y; Zhao C
Vector Borne Zoonotic Dis; 2023 Nov; 23(11):588-594. PubMed ID: 37699252
[No Abstract] [Full Text] [Related]
32. A rat model for hepatitis E virus.
Debing Y; Mishra N; Verbeken E; Ramaekers K; Dallmeier K; Neyts J
Dis Model Mech; 2016 Oct; 9(10):1203-1210. PubMed ID: 27483350
[TBL] [Abstract][Full Text] [Related]
33. Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy.
Young KC; Lindsay KL; Lee KJ; Liu WC; He JW; Milstein SL; Lai MM
Hepatology; 2003 Oct; 38(4):869-78. PubMed ID: 14512874
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment.
Aslan AT; Balaban HY
World J Gastroenterol; 2020 Oct; 26(37):5543-5560. PubMed ID: 33071523
[TBL] [Abstract][Full Text] [Related]
35. Generation of a Bactrian camel hepatitis E virus by a reverse genetics system.
Zhang W; Ami Y; Suzaki Y; Doan YH; Takeda N; Muramatsu M; Li TC
J Gen Virol; 2021 Jul; 102(7):. PubMed ID: 34242156
[TBL] [Abstract][Full Text] [Related]
36. Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report.
Goyal R; Kumar A; Panda SK; Paul SB; Acharya SK
Antivir Ther; 2012; 17(6):1091-6. PubMed ID: 22910532
[TBL] [Abstract][Full Text] [Related]
37. Immunocompromised rabbit model of chronic HEV reveals liver fibrosis and distinct efficacy of different vaccination strategies.
He Q; Zhang F; Shu J; Li S; Liang Z; Du M; Liu X; Liu T; Li M; Yin X; Pan Q; Lu F; Wang L; Wang L
Hepatology; 2022 Sep; 76(3):788-802. PubMed ID: 35278241
[TBL] [Abstract][Full Text] [Related]
38. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.
Sooryanarain H; Rogers AJ; Cao D; Haac MER; Karpe YA; Meng XJ
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724761
[TBL] [Abstract][Full Text] [Related]
39. Antiviral Candidates for Treating Hepatitis E Virus Infection.
Netzler NE; Enosi Tuipulotu D; Vasudevan SG; Mackenzie JM; White PA
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30885901
[TBL] [Abstract][Full Text] [Related]
40. Whole genome sequencing reveals insights into hepatitis E virus genome diversity, and virus compartmentalization in chronic hepatitis E.
Melchert J; Radbruch H; Hanitsch LG; Baylis SA; Beheim-Schwarzbach J; Bleicker T; Hofmann J; Jones TC; Drosten C; Corman VM
J Clin Virol; 2023 Nov; 168():105583. PubMed ID: 37716229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
